Intracranial Activity of Encorafenib and Binimetinib followed by Radiotherapy in Patients with Braf Mutated Melanoma and Brain Metastasis: Preliminary Results of the GEM1802/E-Brain Phase II Clinical Trial

Detalle

Iván Márquez-Rodas, Ana Arance, Miguel Ángel Berciano, Roberto Díaz Beveridge, Maria del Carmen Álamo, Almudena García, Maria Gonzalez-Cao, Joana Vidall, Teresa Puértolas, Ainara Soria, Carlos Aguado, Pedro Sánchez Mauriño, Izaskun Valduvieco, Raquel Delgado, Antonio Conde, Palmira Foro, Pedro José Prada, Enrique Puertas, Ana Álvarez González, Alfonso Berrocal. Intracranial Activity of Encorafenib and Binimetinib followed by Radiotherapy in Patients with Braf Mutated Melanoma and Brain Metastasis: Preliminary Results of the GEM1802/E-Brain Phase II Clinical Trial.